COVIP study

Corona Virus disease (COVID19) in Very Elderly
Intensive care Patients (VIPs)

A multinational, multicenter study of outcomes and prognostic factors in coronavirus disease (COVID-19) in very old intensive care patients.
The coronavirus SARS-CoV-2 is currently affecting thousands of patients across many countries and there is an urgent need to investigate patient characteristics and outcome trajectories.
The VIP network which has previously (2016-2019) conducted the most extensive prospective studies (VIP1, VIP2) on elderly ICU patients, has immediately deployed this study of elderly COVID19 patients starting now.

Click to register your ICU now

You will receive an further information when you register.
See the COVIP page for information, protocol, documents, notes and ethical approval etc.

VIP1 and VIP2 studies

The VIP1 and VIP2 studes were international, multicenter studies of the old intensive care unit population.
The data from VIP2 is currently being analyzed and published.

The first VIP2 publication has been published in Intensive Care Medicine (freely available):

The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive care medicine, 10.1007/s00134-019-05853-1.

The Barcelona symposium is cancelled

VIP symposium in Barcelona: June 25th-26th 2020.
"Too old for the ICU?"
Visit the conference website: elderlyicu2020.com

Endorsed by ESICM.